Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $177.00 price target on Tenet Healthcare (NYSE: THC).

The analyst commented, “Inpatient acute and ASC nurse openings reflect typical seasonality into 2025 and 4Q24 vs. 3Q24 trends suggest stability. Physician data outperforms peers HCA & SGRY on more evidence of pricing discipline in more difficult to hire specialties.”

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $140.89 yesterday.

You May Also Be Interested In

• Hyperion DeFi, Inc. (HYPD) PT Raised to $7.10 at Cantor Fitzgerald
• Foot traffic at Taco Bell for week of August 3 down 8%, compared to a near 20% decline in mid-July - Placer.AIdata
• LENSAR Inc. (LNSR) PT Raised to $9 at BTIG